India ranks sixth in global IP filings, with over 55% from residents. But filing is only the start. As global capital demands enforceable, portable IP, early governance will determine long-term ...

By freeing enzyme-driven chemical reactions from the limitations imposed by cells, exozyme biosolutions eliminate the scaling bottleneck that has hampered commercial success in the synthetic biology ...

While ideas are free, how one expresses ideas, brands their business, and builds inventions are not. In the rise of innovation, invention, and content creation, those who produce original ideas—such ...

The DOST-Technology Application and Promotion Institute on Friday said it aims for a 5% increase in intellectual property filings and commercialization and adoption of supported technologies this year ...

China’s National Intellectual Property Administration (CNIPA) and Ministry of Industry and Information Technology (MITT) have unveiled a package of policy measures designed to strengthen intellectual ...

After decades of accusations over counterfeiting foreign brands, Chinese companies are now assuming dual roles: as not only IP violators, but also IP proprietors. BYD, DeepSeek, and Pop Mart are among ...

“Consumers across all five regions predominantly perceive the greatest benefits from innovations in ‘Digital Communication,’ followed by ‘Food and Nutrition,’ ‘Household Appliances,’ and ‘Computer ...

Disability advocates are speaking out as the U.S. Supreme Court prepares to take on a case that hinges on whether a diagnosis of intellectual disability should be based on more than an IQ score. The ...

Lauren Giella is a Senior Reporter based in New York. She reports on Newsweek's rankings content, focusing on workplace culture, health care and sustainability, profiling business leaders and ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Biotech companies that use gene editing tools can face intellectual property (IP) challenges during commercialization. That’s the view of Austin Hallgren, strategic account manager for bioproduction ...